Suchergebnisse

Zur Trennung von (zerstrittenen) Gesellschaftern werden zunehmend Mechanismen diskutiert, die unter Russian Roulette, Texas Shoot Out und ähnlich martialischen Bezeichnungen bekannt sind. Sie versprechen neben einer raschen Lösung durch Ausscheiden eines Gesellschafters auch die Ermittlung einer angemessenen Abfindungshöhe mittels eines speziellen Preisfindungsmechanismus. Sebastian S. Schmitt analysiert diese facettenreichen Klauseln aus unterschiedlichen Blickwinkeln. Neben einer klassischen materiellen Prüfung nach deutschem Recht lädt ihre internationale Verbreitung zu einer rechtsvergleichenden Betrachtung ein, die sich auf den französischen und US-amerikanischen Raum konzentriert. Abgerundet wird die Untersuchung durch einen Blick auf die ökonomischen, insbesondere spieltheoretischen Hintergründe. So ergibt sich ein umfassendes Bild, das den praktischen Wert der Klauseln herausstellt, aber auch vor ihrer unreflektierten Verwendung warnt.

In den letzten zehn Jahren sind die Fallzahlen gestiegen und mit ihnen die Anzahl der Operationen (Steigerung um 25 Prozent). Nun gilt es, die damit verbundenen administrativen Prozesse optimal und mit geringem Zusatzaufwand zu integrieren.

The COVID-19 outbreak has cut China's supply of and raised the world's demand for face masks, disinfectants, ventilators, and other critical medical goods. This article studies the economic and political factors that are associated with China's exports of medical equipment during the first two months of the global pandemic. Regression results show that-controlled for demand factors-countries with stronger past economic ties with China import more critical medical goods from China at both the national level and the level of Chinese provinces. Friendly political relations, such as the twinning of provinces, appear to work as a substitute for pre-existing economic ties at the provincial level. These findings imply that, to secure access to medical equipment in crises, countries are well advised to either diversify their sources or to develop closer relations with Beijing and China's provinces.

The COVID-19 outbreak has cut China's supply of and raised the world's demand for face masks, disinfectants, ventilators, and other critical medical goods. This article studies the economic and political factors that are associated with China's exports of medical equipment during the first two months of the global pandemic. Regression results show that - controlled for demand factors - countries with stronger past economic ties with China import more critical medical goods from China at both the national level and the level of Chinese provinces. Friendly political relations, such as the twinning of provinces, appear to work as a substitute for pre-existing economic ties at the provincial level. These findings imply that, to secure access to medical equipment in crises, countries are well advised to either diversify their sources or to develop closer relations with Beijing and China's provinces.

China ist einer der weltweit wichtigsten Exporteure von Medizinprodukten wie beispielsweise Gesichtsmasken oder Desinfektionsmittel. Daher nahmen chinesische Unternehmen eine herausragende Rolle als Lieferant dieser Produkte während des globalen Ausbruchs der COVID-19-Pandemie im Frühjahr 2020 ein. Die Autoren untersuchen mithilfe monatlicher Handelsdaten, die von der chinesischen Zollverwaltung erhoben und veröffentlicht werden, die Veränderungen der Handelsströme für medizinische Güter während der Krise. Dabei unterteilen sie die Daten in kommerziellen Handel und Hilfslieferungen. Sie kommen zu dem Ergebnis, dass sowohl Handelsbeziehungen, die bereits vor der Krise bestanden, als auch politische Verbindungen zu den jeweiligen chinesischen Provinzen für importierende Staaten hilfreich waren, um Zugang zu den knappen Gütern während der Krise zu erlangen. ; China assumed an important role during the worldwide outbreak of COVID-19 as the main exporter of critical medical goods such as face masks and disinfectants. We use official monthly trade data from China Customs to investigate the emerging trade patterns, both for commercial exports and donations of medical goods. We find that both existing trade linkages and political ties to Chinese provinces can help to attract Chinese medical goods.

Plant molecular farming (PMF) is a convenient and cost-effective way to produce high-value recombinant proteins that can be used in the production of a range of health products, from pharmaceutical therapeutics to cosmetic products. New plant breeding techniques (NPBTs) provide a means to enhance PMF systems more quickly and with greater precision than ever before. However, the feasibility, regulatory standing and social acceptability of both PMF and NPBTs are in question. This paper explores the perceptions of key stakeholders on two European Union (EU) Horizon 2020 programmes–Pharma-Factory and Newcotiana–towards the barriers and facilitators of PMF and NPBTs in Europe. One-on-one qualitative interviews were undertaken with N = 20 individuals involved in one or both of the two projects at 16 institutions in seven countries (Belgium, France, Germany, Italy, Israel, Spain and the UK). The findings indicate that the current EU regulatory environment and the perception of the public towards biotechnology are seen as the main barriers to scaling-up PMF and NPBTs. Competition from existing systems and the lack of plant-specific regulations likewise present challenges for PMF developing beyond its current niche. However, respondents felt that the communication of the benefits and purpose of NPBT PMF could provide a platform for improving the social acceptance of genetic modification. The importance of the media in this process was highlighted. This article also uses the multi-level perspective to explore the ways in which NPBTs are being legitimated by interested parties and the systemic factors that have shaped and are continuing to shape the development of PMF in Europe.

The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.